APA (7th ed.) Citation

JY, Y., T, W., V, P., EW, G., MJ, C., JB, B., & T, S. (2019). Sodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: Evolving questions, evolving answers. Diabetes, obesity & metabolism, 21(5), 1223. https://doi.org/10.1111/dom.13647

Chicago Style (17th ed.) Citation

JY, Yang, Wang T, Pate V, Gower EW, Crowley MJ, Buse JB, and Stürmer T. "Sodium-glucose Co-transporter-2 Inhibitor Use and Risk of Lower-extremity Amputation: Evolving Questions, Evolving Answers." Diabetes, Obesity & Metabolism 21, no. 5 (2019): 1223. https://doi.org/10.1111/dom.13647.

MLA (9th ed.) Citation

JY, Yang, et al. "Sodium-glucose Co-transporter-2 Inhibitor Use and Risk of Lower-extremity Amputation: Evolving Questions, Evolving Answers." Diabetes, Obesity & Metabolism, vol. 21, no. 5, 2019, p. 1223, https://doi.org/10.1111/dom.13647.